179 related articles for article (PubMed ID: 30003661)
1. An efficient and facile green synthesis of bisindole methanes as potential Mtb FtsZ inhibitors.
Khadkikar P; Goud NS; Mohammed A; Ramamoorthy G; Ananthathatmula R; Doble M; Rizvi A; Banerjee S; Ravi A; Alvala M
Chem Biol Drug Des; 2018 Dec; 92(6):1933-1939. PubMed ID: 30003661
[TBL] [Abstract][Full Text] [Related]
2. Identification of TB-E12 as a novel FtsZ inhibitor with anti-tuberculosis activity.
Lin Y; Zhang H; Zhu N; Wang X; Han Y; Chen M; Jiang J; Si S
Tuberculosis (Edinb); 2018 May; 110():79-85. PubMed ID: 29779778
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics analysis of the effects of GTP, GDP and benzimidazole derivative on structural dynamics of a cell division protein FtsZ from
Hakeem S; Singh I; Sharma P; Uppal A; Khajuria Y; Verma V; Uversky VN; Chandra R
J Biomol Struct Dyn; 2019 Oct; 37(16):4361-4373. PubMed ID: 30466358
[TBL] [Abstract][Full Text] [Related]
4. Identification of anti-tuberculosis agents that target the cell-division protein FtsZ.
Lin Y; Zhu N; Han Y; Jiang J; Si S
J Antibiot (Tokyo); 2014 Sep; 67(9):671-6. PubMed ID: 24984796
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore based approach to screen and evaluate novel Mycobacterium cell division inhibitors targeting FtsZ - A modelling and experimental study.
Mitra K; Chadha A; Doble M
Eur J Pharm Sci; 2019 Jul; 135():103-112. PubMed ID: 31034983
[TBL] [Abstract][Full Text] [Related]
6. Drug repurposing: Fusidic acid as a potential inhibitor of M. tuberculosis FtsZ polymerization - Insight from DFT calculations, molecular docking and molecular dynamics simulations.
Akinpelu OI; Lawal MM; Kumalo HM; Mhlongo NN
Tuberculosis (Edinb); 2020 Mar; 121():101920. PubMed ID: 32279872
[TBL] [Abstract][Full Text] [Related]
7. Discovery of anti-TB agents that target the cell-division protein FtsZ.
Kumar K; Awasthi D; Berger WT; Tonge PJ; Slayden RA; Ojima I
Future Med Chem; 2010 Aug; 2(8):1305-23. PubMed ID: 21339840
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory activity of traditional plants against Mycobacterium smegmatis and their action on Filamenting temperature sensitive mutant Z (FtsZ)-A cell division protein.
Ravindran R; Chakrapani G; Mitra K; Doble M
PLoS One; 2020; 15(5):e0232482. PubMed ID: 32357366
[TBL] [Abstract][Full Text] [Related]
9. Novel trisubstituted benzimidazoles, targeting Mtb FtsZ, as a new class of antitubercular agents.
Kumar K; Awasthi D; Lee SY; Zanardi I; Ruzsicska B; Knudson S; Tonge PJ; Slayden RA; Ojima I
J Med Chem; 2011 Jan; 54(1):374-81. PubMed ID: 21126020
[TBL] [Abstract][Full Text] [Related]
10. Screening and Development of New Inhibitors of FtsZ from M. Tuberculosis.
Mathew B; Hobrath JV; Ross L; Connelly MC; Lofton H; Rajagopalan M; Guy RK; Reynolds RC
PLoS One; 2016; 11(10):e0164100. PubMed ID: 27768711
[TBL] [Abstract][Full Text] [Related]
11. A rhodanine derivative CCR-11 inhibits bacterial proliferation by inhibiting the assembly and GTPase activity of FtsZ.
Singh P; Jindal B; Surolia A; Panda D
Biochemistry; 2012 Jul; 51(27):5434-42. PubMed ID: 22703373
[TBL] [Abstract][Full Text] [Related]
12. Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ.
Jaiswal R; Beuria TK; Mohan R; Mahajan SK; Panda D
Biochemistry; 2007 Apr; 46(14):4211-20. PubMed ID: 17348691
[TBL] [Abstract][Full Text] [Related]
13. SAR studies on trisubstituted benzimidazoles as inhibitors of Mtb FtsZ for the development of novel antitubercular agents.
Awasthi D; Kumar K; Knudson SE; Slayden RA; Ojima I
J Med Chem; 2013 Dec; 56(23):9756-70. PubMed ID: 24266862
[TBL] [Abstract][Full Text] [Related]
14. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents.
Huang Q; Kirikae F; Kirikae T; Pepe A; Amin A; Respicio L; Slayden RA; Tonge PJ; Ojima I
J Med Chem; 2006 Jan; 49(2):463-6. PubMed ID: 16420032
[TBL] [Abstract][Full Text] [Related]
15. Development of ssDNA aptamers as potent inhibitors of Mycobacterium tuberculosis acetohydroxyacid synthase.
Baig IA; Moon JY; Lee SC; Ryoo SW; Yoon MY
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt A):1338-50. PubMed ID: 25988243
[TBL] [Abstract][Full Text] [Related]
16. Novel pyridopyrazine and pyrimidothiazine derivatives as FtsZ inhibitors.
Mathew B; Srivastava S; Ross LJ; Suling WJ; White EL; Woolhiser LK; Lenaerts AJ; Reynolds RC
Bioorg Med Chem; 2011 Dec; 19(23):7120-8. PubMed ID: 22024272
[TBL] [Abstract][Full Text] [Related]
17. FtsZ: a novel target for tuberculosis drug discovery.
Huang Q; Tonge PJ; Slayden RA; Kirikae T; Ojima I
Curr Top Med Chem; 2007; 7(5):527-43. PubMed ID: 17346197
[TBL] [Abstract][Full Text] [Related]
18. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
[TBL] [Abstract][Full Text] [Related]
19. FtsZ inhibition and redox modulation with one chemical scaffold: Potential use of dihydroquinolines against mycobacteria.
Duggirala S; Napoleon JV; Nankar RP; Senu Adeeba V; Manheri MK; Doble M
Eur J Med Chem; 2016 Nov; 123():557-567. PubMed ID: 27517804
[TBL] [Abstract][Full Text] [Related]
20. 2/3D-QSAR, molecular docking and MD simulation studies of FtsZ protein targeting benzimidazoles derivatives.
Ahamad S; Islam A; Ahmad F; Dwivedi N; Hassan MI
Comput Biol Chem; 2019 Feb; 78():398-413. PubMed ID: 30602415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
